2nd Global Cardiology Summit - 2023

• Track 1: Congenital Heart Disease and Pediatrics
• Track 2: Risk factors and Nutrition
• Track 3: Cardiac Imaging
• Track 4: Valvular Heart Disease
• Track 5: Coronary Heart Diseases
• Track 6: Cardiac Ventricular Remodeling
• Track 7: Cardiac Diagnostic Test
• Track 8: Cardiothoracic Surgery
• Track 9: Cardiac Toxicity
• Track 10: Cardiovascular Imaging-MRI
• Track 11: Pediatric Cardiac Nanomedicine
• Track 12: Cardiology Case Reports
• Track 13: Myocarditis and Cardiomyopathies
• Track 14: Pediatric Heart Transplantation
• Track 15: Cardiac Pharmacology
• Track 16: Molecular Cardiology
• Track 17: Future Medicine on Cardiology
• Track 18: Cardio-Oncology
• Track 19: Acute and Chronic Cardiac Care
• Track 20: Lipidology & Preventive Cardiology
• Track 21: Hypertension and Healthcare
• Track 22: Cardiovascular Engineering
• Track 23: Cardiovascular Interventions
• Track 24: Nephrocardiology
• Track 25: Electrocardiography
• Track 26: Cardiac Surgery
• Track 27: Stem Cell Research on Cardiology
• Track 28: Cardiac Anaesthesiology

• The entire body of the abstract, excluding tables, must not exceed 250 words. Spaces are not included in this number. Title, authors’ names, affiliations, figures, and tables are not included in the character count.
• The abstract may be structured (i.e., abstracts divided into sections using terms such as Introduction, Methods, Results, Conclusions, etc.) or unstructured.
• Do not use bold type or underline formatting. Italic type is acceptable.
• Text may be in multiple paragraphs.
• Any references should be noted as citations within the text and not as footnotes at the end

FOCUS OF THE CONFERENCE

• Design common risk stratification tools in cardiovascular medicine.
• Discuss the most updated guidelines for cardiovascular disease management.
• Recognize the most relevant evidence in stroke prevention.
• Review effective strategies for prevention of sudden death, including appropriate Management of ventricular arrhythmias.
• Compare effective preventive strategies in patients with atrial fibrillation and other atrial arrhythmia.
• Identify risk factors for heart failure and become familiar with strategies to prevent complications in patients with already established heart failure.
• Describe the key clinical elements to risk stratify individuals with hypertrophy Cardiomyopathy.
• Cite the critical steps in risk reduction in patients with established coronary disease.
• Manage cardiovascular risk in primary prevention.
• Revise the most updated guidelines for prevention of infective endocarditis.
• Review the most updated recommendations for primary and secondary prevention of deep vein thrombosis.

WHY YOU SHOULD ATTEND 2ND GLOBAL CARDIOLOGY SUMMIT - 2023

2nd Global Cardiology Summit 2023 is among the World's leading Scientific Conference to bring together worldwide distinguished healthcare experts in the field of cardiology, researchers, public health professionals, professors, academic scientists, industry researchers, scholars to exchange their ideas. You can take the opportunities of lectures from industry leaders, session on hot topics, interaction with company’s representatives, Meeting delegates and interaction over lunch and coffee breaks. The objective of this meeting is to stimulate new ideas for treatment and analyze the current market for the future direction of cardiovascular drugs, devices, and diagnostics, with a greater prominence on newer products that will be beneficial across the spectrum of Cardiology. We expect to welcome healthcare professionals from over 100 countries. We also have global faculty who are leading experts in their fields. Gain valuable awareness from these prominent professionals from skilled institutions.

2nd Global Cardiology Summit - 2023 will gather world-class teachers, scientists and cardiologists to discuss methodology for ailment remediation for heart, Electrocardiography, Heart Failure, Nuclear Cardiology conferences, cardiology meetings are planned to give varying and stream preparing that will keep helpful specialists next to each other of the issues impacting the expectation, finding and treatment of cardiovascular contamination. The assembling will be dealt with around the subject “Technological and clinical advances in cardiology".

PARTICIPANTS - FIVE REASONS WHY YOU SHOULD ATTEND THE CONGRESS:

• Identify pertinent evolution of Health technologies in cardiovascular fields.
• Translate technological capabilities into clinical applications, relevant to daily practice.
• Connect and exchange with technology developers.
• Network with Health main stakeholders in cardiovascular fields.
• Contribute to driving and directing the fast growing field of Health..

THE BENEFITS PROVIDED TO THE ATTENDEES ARE:

• Certificates will be provided to all speakers, delegates and students
• Opportunity to meet world’s renowned at this event
• Keynote forums by Prominent Surgeons & Professors
• Best platform for Global business and networking opportunities
• Oral/Poster presentations by Young Researchers
• Best poster award for students